IL17A and acute respiratory distress syndrome: In ALI model, IL-17A treatment triggered robust epithelial inflammation, resulting in significant apoptosis of viral-infected and bystander cell death, disruption of barrier integrity, and enhanced viral spread, supporting the in vivo findings.